Patents by Inventor Aisha N. Hasan

Aisha N. Hasan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of Selecting T Cell Line and Donor Thereof for Adoptive Cellular Therapy
    Publication number: 20220023417
    Abstract: Disclosed herein are methods of selecting an allogeneic T cell line for therapeutic administration to a patient having or suspected of having a pathogen or cancer. Also disclosed are methods of selecting a donor from whom to derive an allogeneic T cell line for therapeutic administration to a patient having or suspected of having a pathogen or cancer.
    Type: Application
    Filed: October 8, 2021
    Publication date: January 27, 2022
    Applicant: Memorial Sloan Kettering Cancer Center
    Inventors: Richard J. O'Reilly, Ekaterina Doubrovina, Guenther Koehne, Aisha N. Hasan, Susan E. Prockop
  • Methods of selecting T cell line and donor thereof for adoptive cellular therapy
    Patent number: 11173205
    Abstract: Disclosed herein are methods of selecting an allogeneic T cell line for therapeutic administration to a patient having or suspected of having a pathogen or cancer. Also disclosed are methods of selecting a donor from whom to derive an allogeneic T cell line for therapeutic administration to a patient having or suspected of having a pathogen or cancer.
    Type: Grant
    Filed: November 4, 2015
    Date of Patent: November 16, 2021
    Assignee: Memorial Sloan Kettering Cancer Center
    Inventors: Richard J. O'Reilly, Ekaterina Doubrovina, Guenther Koehne, Aisha N. Hasan, Susan E. Prockop
  • Methods of Selecting T cell Line and Donor Thereof for Adoptive Cellular Therapy
    Publication number: 20170319683
    Abstract: Disclosed herein are methods of selecting an allogeneic T cell line for therapeutic administration to a patient having or suspected of having a pathogen or cancer. Also disclosed are methods of selecting a donor from whom to derive an allogeneic T cell line for therapeutic administration to a patient having or suspected of having a pathogen or cancer.
    Type: Application
    Filed: November 4, 2015
    Publication date: November 9, 2017
    Applicant: Memorial Sloan Kettering Cancer Center
    Inventors: Richard J. O'Reilly, Ekaterina Doubrovina, Guenther Koehne, Aisha N. Hasan, Susan E. Prockop